期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Effective cofactor complex purification using nanobeads
1
作者 Makoto Umeda Tatsuya Uebi +3 位作者 Naoya Maekawa Yuka Masaike Hiroshi Handa Takeshi Imai 《Journal of Biosciences and Medicines》 2013年第3期5-10,共6页
Drug target factor complex identification is necessary for evidence based drug discovery. Previous study showed that using small chemical immobilized magnetic nanobeads the chemical target factors were effectively pur... Drug target factor complex identification is necessary for evidence based drug discovery. Previous study showed that using small chemical immobilized magnetic nanobeads the chemical target factors were effectively purified and identified. Here we succeeded to purify the chemical target factor complex, so called cofactor(s). Arginine exhibits a variety of biological activities through a complex and highly regulated set of pathways that remain incompletely understood at both the whole-body and the cellular levels. The aim of this study is to develop and validate effective purification system for arginine target complex. New arginine target protein (arginine interacting factor 4, AIF4) was purified and identified. Using recombinant AIF4 protein and arginine-immobilized magnetic nanobeads, AIF4 cofactor, AIF4-BP1, were purified. Interaction of AIF4 and AIF4-BP1 was detected in arginine-dependent manner, suggesting arginine receptor complex formation. This nanobeads technology is more than 30-fold efficient purification efficient than general purification technology. 展开更多
关键词 ARGININE Nanobeads
暂未订购
Prohibitins, novel vitamin K2 target factors in osteoblast 被引量:1
2
作者 Tatsuya Uebi Makoto Umeda +3 位作者 Naoya Maekawa Satoshi Karasawa Hiroshi Handa Takeshi Imai 《Journal of Biosciences and Medicines》 2013年第3期1-4,共4页
Vitamin K2 (VK2, menaquinone) is a drug for osteoporosis. VK2 acts as a cofactor for γ-glutamyl carboxylase, which catalyzes the carboxylation of specific glutamic acid residues (γ-carboxylation) of substrate protei... Vitamin K2 (VK2, menaquinone) is a drug for osteoporosis. VK2 acts as a cofactor for γ-glutamyl carboxylase, which catalyzes the carboxylation of specific glutamic acid residues (γ-carboxylation) of substrate proteins. Here we demonstrate that VK2 also regulate osteoblastgenic marker gene expression. Using VK2-immobilzed nanobeads new target proteins were purified and identified from osteoblastic cell line. They are prohibitin 1 and 2 (PHB1 & 2), respectively. To confirm the PHBs function on VK2-dependent transcription, PHB1 & 2 were knock-down and osteocalcin gene 2 transcriptions were analyzed, indicating that PHBs regulate VK2-dependent transcription. Taken together PHBs are VK2 target proteins for osteoblastgenic transcription. 展开更多
关键词 VITAMIN K2 PROHIBITIN OSTEOBLAST Runt-Related TRANSCRIPTION Factor 2 (Runx2)
暂未订购
PGJIFs, new mitochondrial PGJ2 target factors, regulate cell proliferation
3
作者 Makoto Umeda Tatsuya Uebi +2 位作者 Naoya Maekawa Hiroshi Handa Takeshi Imai 《Journal of Biosciences and Medicines》 2013年第3期11-15,共5页
Our previous study showed that prostaglandin J2 (PGJ2) interacting factor (PGJIF) was purified and identified with magnetic nanobeads. Farther analysis of PGJ2 function shows that PGJ2 inhibits cell proliferation and ... Our previous study showed that prostaglandin J2 (PGJ2) interacting factor (PGJIF) was purified and identified with magnetic nanobeads. Farther analysis of PGJ2 function shows that PGJ2 inhibits cell proliferation and rhodamine 123 incorporation. Using PGJ2- immobilized nanobeads, two target proteins were also purified and identified as PGJIF1 and PGJIF2. PGJIF1 genetic analysis showed that PGJIF1 regulates cell proliferation as well as rhodamine 123 incorporation in mitochondria, indicating that PGJIF1 is one of the PGJ2 target proteins. The other target protein, PGJIF2, changes its intracellular localization in PGJ2-dependent manner. Using nanobeads technology, two PGJ2 target factors were purified and identified. 展开更多
关键词 PROSTAGLANDIN J2 Nanobeads MITOCHONDRIA
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部